Bayer concentrates its research and development activities on innovative treatment options for diseases with a high unmet medical need to prolong lives and improve patients´ quality of life.
While much progress has been made in the treatment of cancer in recent years, the pursuit continues to improve diagnostic and treatment modalities.
In this context, Bayer is committed to advancing the science of cancer, and translating this science into effective therapies that can help people with cancer live longer.
Focus on different cancer types, together with partners
Our pipeline explores specific treatment approaches for many different types of tumors including for example breast, colorectal and prostate cancer, as well as liver, kidney and lung cancer and different blood cancers (lymphomas).
Another important aspect of our strategy is joining forces with external partners in academia and industry that have specialized knowledge to take on the challenges of developing and making available new products for the benefit of patients.